Advisory Board and Editors Hematology

Journal Factsheet
A one-page PDF to help when considering journal options with co-authors
Download Factsheet
I told my colleagues that PeerJ is a journal where they need to publish if they want their paper to be published quickly and with the strict peer review expected from a good journal.
Sohath Vanegas,
PeerJ Author
View author feedback

Yasmina M Abd-Elhakim

Prof. Dr. Yasmina Mohammed Abd-Elhakim is a Professor in the Forensic Medicine and Toxicology Department in the Faculty of Veterinary Medicine, Zagazig University, Egypt. Her major area of expertise is the use of eco-friendly mitigation strategies to combat the hazards of environmental pollutants. Additionally, she has a special interest in the therapeutic uses of arthropods venoms, particularly in neurodegenerative diseases and cancer. She has 60 papers in prestigious international journals and 2 book chapters, h-index 19, and more than 1000 citations based on the Scopus database. She reviewed about 870 manuscripts for highly impacted journals in the field of toxicology and environmental pollution based on the Publon database. She has been included in the editorial board of several highly impacted international journals. She received various awards including The Egyptian State Encouragement Award in "Agricultural sciences" in 2019, the Publons peer reviewer award as a Top Reviewers for Pharmacology & Toxicology in 2018 and 2019, and the international publication's award from Zagazig University (2015-2019).

Dorothee Bienzle

Professor of Veterinary Pathology at University of Guelph & University Research Leadership Chair

Interested in a better understanding of animal diseases and their counterparts in humans. Also interested in developing new tools to investigate animal diseases

Simone Cesaro

Graduated in Medicine in 1988 at the University of Padua. Pediatrician in 1992. I have been actively involved in pediatric hematology and oncology, especially in chemotherapy for leukemia and lymphoma, supportive care, and early and late effects of treatment, and hematopoietic stem cell transplantation (HSCT).

Appointed in 2009 Director of the Pediatric Hematology and Oncology Unit at the Department of Pediatrics in Verona. Member of the scientific committees of several working groups including Pediatrics (for MASCC), Supportive Care (for SIOP), Aplastic Anemia, Infection (for EBMT), hematopoietic stem cell transplant, Infection, Supportive care (for AIEOP). Appointed in 2005 and 2015 Chairman of the Supportive Care Group and Infection of AIEOP (Italian Association of Pediatric Hematology Oncology), respectively. Appointed in 2010, Chairman of Infectious Diseases Working Party of European Society for Blood and Marrow Transplantation.

Author of more than 200 publications in peer-reviewed journals. Medical advisor of the charities Paul O’Gorman Lifeline (UK) and Lifeline Italia, liaising with and advising pediatric hematology and oncology centers in Russia, Ukraine, Georgia and Kyrgyzstan.

Christopher Cooper

Senior Lecturer in Biological Sciences at the University of Huddersfield, since 2015. Previously Junior Research Fellow, College Lecturer In Biochemistry and various postdocs at the University of Oxford (2013-15). Working on DNA replication, genome integrity and transcription factors in human cancers (and also in prokaryotes). Additional interests in phylogenomics and novel protein expression systems.

Carlos Eurico Fernandes

Dr. Carlos Eurico Fernandes is Professor within the Experimental Pathology Laboratory at the Institute of Biosciences, Federal University of Mato Grosso do Sul, Brazil.

His research within the Experimental Pathology Laboratory focuses on descriptive and functional histology, with an emphasis on biometric, histological, histopathological and histomorphometric analyses, having fish and anurans as experimental models.

Hendrik B. Feys

Principal Investigator of the Transfusion Research Center, Belgian Red Cross Flanders, Belgium. Visiting Professor at Ghent University, Faculty of Medicine.

Roi Gazit

Roi Gazit, PhD., is Principal Investigator of Hematopoietic Stem Cell (HSC) transcriptome laboratory at the Ben-Gurion University of the Negev, Israel. He is a member of the National Institute for Biotechnology in the Negev (NIBN), and the Center for Regenerative Medicine and Stem Cells at BGU. Roi earned a B.Sc. and M.Sc. in life science and developmental biology from the Hebrew University of Jerusalem. He obtained PhD. in immunology, under supervision of Ofer Mandelboim, studying NK-cell in vivo, including the generation of the first NK specific mouse model and elucidation of novel NK-cell abnormalities in human patients. He conducted postdoctoral studies at the Harvard Medical School, at Derrick J. Rossi laboratory, focusing on the identification and utilization of HSCs’ genes, including reprogramming of committed blood cells into HSCs using defined transcription-factors and generation of a novel HSC-reporter mouse. His laboratory at the Ben-Gurion University is studying HSCs’ transcriptome along normal development, during immune-challenges, and the direct reprogramming of adult blood cells into HSCs.

Md Asiful Islam

Dr Md Asiful Islam completed his PhD (Fast Track, Passed with Grade 1, Pass without correction) in Genetics & Autoimmunity from Human Genome Centre, Universiti Sains Malaysia (November 2018) under Professor Dr Siew Hua Gan following completing BSc in Biochemistry & Molecular Biology (Jahangirnagar University, Dhaka, Bangladesh). He achieved Malaysia International Scholarship and USM Vice-Chancellor Award during his PhD and working as a Senior Lecturer at the Department of Haematology, School of Medical Sciences, Universiti Sains Malaysia since September 2019.

Besides PeerJ, he has been working as an Academic Editor for Nature Scientific Data, PLOS ONE, BMC Rheumatology, Autoimmunity Highlights, Endocrine, Metabolic & Immune Disorders - Drug Targets, Current Immunology Reviews and Current Rheumatology Reviews. He has published 60+ Web of science-indexed articles (Impact factor: 210+) with 1200+ citations (h-index 19).

Dr Asiful's research interest covers different research areas of Medical Sciences including Haematology, Immunology, Pharmacology, Molecular Genetics and Neurosciences. He is currently focused on developing and executing systematic reviews and meta-analyses decoding various research questions of Medical Sciences.

Alex Kentsis

Assistant Professor of Pediatrics at the Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College of Cornell University.

He leads research in the functional proteomics and genomic plasticity of refractory childhood cancers.

Can Küçük

Dr. Can Küçük currently works at Dokuz Eylül University and İzmir Biomedicine and Genome Center (IBG) in Turkey as a faculty and independent PI with his own research group. He has authored research articles in high profile journals on molecular pathobiology, genetics, or diagnostics of NK and/or T cell malignancies.

Dr. Küçük graduated from the Department of Molecular Biology and Genetics at Middle East Technical University (METU) in 2005. He got his Ph.D degree in Cancer Biology and Oncology from Eppley Institute for Research in Cancer and Allied Diseases at University of Nebraska Medical Center (UNMC) in 2012. He worked as a post-doc in the Department of Pathology at UNMC and then at City of Hope Medical Center.

His group investigates the etiology of lymphoid malignancies using personalized medicine approach. In particular, targeted sequencing, whole transcriptome sequencing, or epigenome sequencing are applied on tumor samples to identify aberrant genes or pathways leading to development of these neoplasms. His group aims to:

1) identify novel recurrent aberrations that can be targeted by rational drugs.
2) develop companion diagnostics methodologies for personalized medicine
3) identify novel biomarkers of diagnosis, prognosis or disease management.

Ian J Majewski

My research group is working to identify genetic mutations that contribute to the development of leukaemia, and studying how these mutations influence a patient’s response to therapy. The cancer landscape is both complex and dynamic and we're using genomic approaches to study how cancer cells evolve in response to treatment.

Laurent Metzinger

Laurent Metzinger has completed his PhD in Biological Sciences and Pharmaceutical studies in Strasbourg, France and was a postdoctoral fellow from the University of Oxford (UK) in a leading lab on Duchenne muscular Dystrophy (Pr. Kay Davies). He works on microRNA regulation in the HEMATIM team in Amiens, and focuses on anemia and related vascular disorders associated with Chronic Kidney DIsease. He has authored some of the first papers showing a role for microRNAs in CKD and published in reputed journals, including Nature and Cell. He teaches Biochemistry, Genetics and Molecular Biology in the Pharmacy School of Amiens (Université de Picardie Jules Verne).